BORMANN-KENNEDY BARBARA-JEAN ANNE

Track

Insider profile

BORMANN-KENNEDY BARBARA-JEAN ANNE's trades of Xeris Biopharma Holdings Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-05 2026-06-04
PlS Planned sale
51,627 -12.5%
173.38
US$1,714,597 		51,627 -12.5% 173.38 US$1,714,597
2026-06-04 2026-06-04
PrS Proposed sale
7,210
80.81
US$2,770,123 		7,210 80.81 US$2,770,123
2025-12-15 2025-12-12
PlS Planned sale
64,428 -21.3%
182.12
US$2,264,951 		64,428 -21.3% 182.12 US$2,264,951
2025-12-12 2025-12-12
PrS Proposed sale
15,000
7.01
US$105,150 		15,000 7.01 US$105,150